Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Benicar Abdominal Pain, Diarrhea Problems Not Seen With Other Blood Pressure Drugs November 5, 2014 Staff Writers Add Your Comments New research suggests that sprue-like enteropathy side effects of Benicar, which can cause users to suffer severe abdominal pain and chronic diarrhea, do not appear to be a risk with other blood pressure drugs that are part of the same class of medications, known as angiotensin receptor blockers (ARBs). Over the past two years, evidence has emerged about the link between Benicar and persistent diarrhea, abdominal pain, weight loss and other symptoms associated with the medical condition sprue-like enteropathy. Although the widely used hypertension drug has been on the market for more than 10 years, the first published report linking the Benicar and abdominal problems was not released until August 2012, and the first FDA warnings about the risk of sprue-like enteropathy were not issued until July 2013. Learn More About Benicar Lawsuits Side Effects of Benicar May Cause Diarrhea, Villous Atrophy and Sprue-Like Enteropathy Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Benicar Lawsuits Side Effects of Benicar May Cause Diarrhea, Villous Atrophy and Sprue-Like Enteropathy Learn More SEE IF YOU QUALIFY FOR COMPENSATION Benicar is part of a family of drugs made by Daiichi Sankyo, which all contain the active pharmaceutical ingredient olmesartan. Other members of the Benicar family include Benicar HCT, Azor and Tribenzor. While the abdominal symptoms have been linked to all of the olmesartan drugs, questions have remained about whether the wider class of hypertension drugs known as ARBs may carry a similar risk. Other medications that are part of this class include Atacand, Teveten, Avapro, Cozaar, Micardis and Diovan. ARB Study On Sprue-Like Enteropathy In a study published on-line late last month by the Journal of Clinical Pathology, researchers evaluated reports of serious and potentially life-threatening diarrhea and abdominal pain among users of Benicar in comparison to pain experienced by users of non-olmesartan ARBs. Researchers from Columbia University conducted a retrospective cohort study of patients suffering abdominal pain undergoing upper gastrointestinal endoscopy who were taking ARBs, looking at about 40 patients in all, which were split among users of Benicar and non-olmesartan drugs. According to the findings, half of the patients taking Benicar or another olmesartan-based drug experienced abdominal pain or other indications of sprue-like enteropathy, while only a fifth of the patients taking other ARBs showed any signs of the problems. The study concludes that only olmesartan drugs appear to be linked to pain and associated sprue-like enteropathy symptoms, determining that patients taking other ARB drugs had the same risk of issues as patients not taking any of the drugs who reported abdominal pain. Researchers found that there are no statistically significant differences between Benicar users with abdominal pain and controls for any single abnormality. However, trends toward significance were identified for individual abnormalities and composite outcomes, which “raises the possibility that there is a spectrum of histological changes associated with olmesartan use.” Link Between Abdominal Pain and Benicar Use Benicar was first introduced in the United States in 2002, and has become one of the top-100 drugs prescribed in the United States, generating about $860 million in sales last year. Due to a lack of warnings about the link between Benicar and sprue-like enteropathy, many users of the medication have suffered chronic diarrhea and abdominal pain that continued for years, as doctors were often unaware that the hypertension drug could be causing the symptoms. In July 2012, a group of independent researchers from the Mayo Clinic published the first report on the risk, identifying at least 22 patients from 17 different states who were treated for symptoms consistent with celiac disease while taking Benicar. While treatments for celiac disease were ineffective, the report indicated that once patients stopped taking Benicar, their symptoms of chronic diarrhea and abdominal problems resolved. This was the first published indication that Benicar may cause abdominal symptoms similar to what is seen among individuals with celiac disease. However, the study was not widely reported, and many primary care physicians remained unaware of the potential risk associated with Benicar. In July 2013, the FDA issued a drug safety communication on the issue, providing widespread information to the medical community for the first time about the importance of being aware of the link between abdominal pain from Benicar, indicating that the symptoms of sprue-like enteropathy may appear months or even years after an individual first uses the medication. The federal drug regulators indicated that they found “clear evidence” of a cause and effect relationship between olmesartan and the gastrointestinal problems, with issues often stopping when the medication was no longer used and resuming if the treatment restarts. As more users learn that abdominal pain and diarrhea problems they may have experienced for years may be caused by their blood pressure medication, a growing number of Benicar lawsuits are now being filed in courts throughout the United States. The lawsuits allege that Daiichi Sankyo knew or should have known about this potential risk associated with their blockbuster medication, and withheld information from consumers and the medical community for decades. Tags: Benicar, Daiichi Sankyo, Enteropathy, Forest Laboratories, Hypertension, Sprue More Benicar Lawsuit Stories Benicar Recall Urged in FDA Petition Filed by Public Citizen December 8, 2017 Benicar Settlement to Result in $300M Payment By Drug Maker for Gastrointestinal Injuries August 1, 2017 Benicar Lawsuits Over Diarrhea, Gastrointestinal Problems Filed By Nearly 2,000 July 17, 2017 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025) Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025) Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Benicar Settlement to Result in $300M Payment By Drug Maker for Gastrointestinal Injuries August 1, 2017
Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)